Clinical Trials Browser

OTHER × antineoplaston AS 2-1 × Dermatologic × Clear all

NCT00003509 2020-12-19

Antineoplaston Therapy in Treating Patients With Stage IV Melanoma

Phase 2 Terminated

13 enrolled 5 charts

Melanoma